Jimenez-Valera M, Ruiz-Bravo A, Gómez M C, Ramos-Cormenzana A
Department of Microbiology, Faculty of Pharmacy, Granada, Spain.
J Antimicrob Chemother. 1988 Nov;22(5):707-13. doi: 10.1093/jac/22.5.707.
Iron-overloaded mice were infected with a virulent strain of Yersinia enterocolitica by the oral route to study the effect of antimicrobial treatments. The effects of therapy were assessed by enumeration of viable yersiniae in Peyer's patches and in ileal contents. Combinations of cephalothin and clavulanic acid showed therapeutic effects, which were interpreted as in-vivo synergism, since each component alone was ineffective. Ceftazidime, which is relatively beta-lactamase resistant, showed in-vivo activity similar to that of the combination of cephalothin and clavulanic acid. These results suggest that clavulanic acid is able to protect cephalothin against Y. enterocolitica beta-lactamases in vivo, as has been shown previously in vitro.
通过口服途径用毒力强的小肠结肠炎耶尔森菌菌株感染铁过载小鼠,以研究抗菌治疗的效果。通过对派尔集合淋巴结和回肠内容物中活的耶尔森菌进行计数来评估治疗效果。头孢噻吩和克拉维酸的组合显示出治疗效果,由于每种成分单独使用均无效,因此被解释为体内协同作用。相对耐β-内酰胺酶的头孢他啶显示出与头孢噻吩和克拉维酸组合相似的体内活性。这些结果表明,克拉维酸能够在体内保护头孢噻吩免受小肠结肠炎耶尔森菌β-内酰胺酶的影响,正如先前在体外所显示的那样。